LIG HT-HVEM signaling in keratinocytes controls development of dermatitis

Journal of Experimental Medicine

Volumn 215, Issue 2, 2018, Pages 415-422

  Herro, Rana ^a   Shui, Jr Wen ^a,e   Zahner, Sonja ^a   Sidler, Daniel ^a,f   Kawakami, Yuko ^a   Kawakami, Toshiaki ^a,b   Tamada, Koji ^d   Kronenberg, Mitchell ^a,c   Croft, Michael ^a,b  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^f UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; CELL MARKER; COLLAGEN; HERPESVIRUS ENTRY MEDIATOR; HOUSE DUST ALLERGEN; LIGHT PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; HERPESVIRUS ENTRY MEDIATOR LIGAND; POSTN PROTEIN, HUMAN; SMALL INTERFERING RNA; TNFRSF14 PROTEIN, HUMAN; TNFRSF14 PROTEIN, MOUSE; TNFSF14 PROTEIN, HUMAN; TNFSF14 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; CELL HYPERPLASIA; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; KERATINOCYTE; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SCLERODERMA; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CELL ADHESION MOLECULES; CELL PROLIFERATION; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; HEK293 CELLS; HUMANS; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

EID: 85041400455     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20170536     Document Type: Article

References (28)

1. Anand, S., P. Wang, K. Yoshimura, I.H. Choi, A. Hilliard, Y.H. Chen, C.R. Wang, R. Schulick, A.S. Flies, D.B. Flies, et al. 2006. Essential role of TNF family molecule LIG HT as a cytokine in the pathogenesis of hepatitis. J. Clin. Invest. 116:1045-1051. https ://doi. org /10. 1172 /JCI27083
2. Ando, T., W. Xiao, P. Gao, S. Namiranian, K. Matsumoto, Y. Tomimori, H. Hong, H. Yamashita, M. Kimura, J. Kashiwakura, et al. 2014. Critical role for mast cell Stat5 activity in skin inflammation. Cell Reports. 6:366-376. https ://doi. org /10. 1016 /j. celrep. 2013. 12. 029
3. Bieber, T. 2008. Atopic dermatitis. N. Engl. J. Med. 358:1483-1494. https :// doi. org /10. 1056 /NEJMra074081
4. Chen, C.C., Y.H. Yang, Y.T. Lin, S.L. Hsieh, and B.L. Chiang. 2004. Soluble decoy receptor 3: increased levels in atopic patients. J. Allergy Clin. Immunol. 114:195-197. https ://doi. org /10. 1016 /j. jaci. 2004. 02. 048
5. Ellinghaus, D., H. Baurecht, J. Esparza-Gordillo, E. Rodríguez, A. Matanovic, I. Marenholz, N. Hübner, H. Schaarschmidt, N. Novak, S. Michel, et al. 2013. High-density genotyping study identifies four new susceptibility loci for atopic dermatitis. Nat. Genet. 45:808-812. https ://doi. org /10. 1038 /ng. 2642
6. Herro, R., R.D.S. Antunes, A.R. Aguilera, K. Tamada, and M. Croft. 2015. The Tumor Necrosis Factor Superfamily Molecule LIG HT Promotes Keratinocyte Activity and Skin Fibrosis. J. Invest. Dermatol. 135:2109-2118. https ://doi. org /10. 1038 /jid. 2015. 110
7. Kawakami, Y., K. Yumoto, and T. Kawakami. 2007. An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of Tec family kinases. Allergol. Int. 56:403-409. https ://doi. org /10. 2332 / allergolint. O-07-486
8. Kotani, H., K. Masuda, R. Tamagawa-Mineoka, T. Nomiyama, F. Soga, M. Nin, J. Asai, S. Kishimoto, and N. Katoh. 2012. Increased plasma LIG HT levels in patients with atopic dermatitis. Clin. Exp. Immunol. 168:318-324. https ://doi. org /10. 1111 /j. 1365-2249. 2012. 04576. x
9. Masuoka, M., H. Shiraishi, S. Ohta, S. Suzuki, K. Arima, S. Aoki, S. Toda, N. Inagaki, Y. Kurihara, S. Hayashida, et al. 2012. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J. Clin. Invest. 122:2590-2600. https ://doi. org /10. 1172 /JCI58978
10. Mauri, D.N., R. Ebner, R.I. Montgomery, K.D. Kochel, T.C. Cheung, G.L. Yu, S. Ruben, M. Murphy, R.J. Eisenberg, G.H. Cohen, et al. 1998. LIG HT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity. 8:21-30. https ://doi. org /10. 1016 /S1074-7613(00)80455-0
11. Morimura, S., M. Sugaya, H. Kai, T. Kato, T. Miyagaki, H. Ohmatsu, S. Kagami, Y. Asano, H. Mitsui, Y. Tada, et al. 2012. High levels of LIG HT and low levels of soluble herpesvirus entry mediator in sera of patients with atopic dermatitis. Clin. Exp. Dermatol. 37:181-182. https ://doi. org /10. 1111 /j. 1365-2230. 2011. 04079. x
12. Nishiyama, T., I. Kii, T.G. Kashima, Y. Kikuchi, A. Ohazama, M. Shimazaki, M. Fukayama, and A. Kudo. 2011. Delayed re-epithelialization in periostindeficient mice during cutaneous wound healing. PLoS One. 6:e18410. https ://doi. org /10. 1371 /journal. pone. 0018410
13. Ontsuka, K., Y. Kotobuki, H. Shiraishi, S. Serada, S. Ohta, A. Tanemura, L. Yang, M. Fujimoto, K. Arima, S. Suzuki, et al. 2012. Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblasts. Exp. Dermatol. 21:331-336. https ://doi. org /10. 1111 /j. 1600-0625. 2012. 01454. x
14. Parulekar, A.D., M.A. Atik, and N.A. Hanania. 2014. Periostin, a novel biomarker of TH2-driven asthma. Curr. Opin. Pulm. Med. 20:60-65. https ://doi. org /10. 1097 /MCP. 0000000000000005
15. Salimi, M., J.L. Barlow, S.P. Saunders, L. Xue, D. Gutowska-Owsiak, X. Wang, L.C. Huang, D. Johnson, S.T. Scanlon, A.N. McKenzie, et al. 2013. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J. Exp. Med. 210:2939-2950. https ://doi. org /10. 1084 /jem. 20130351
16. Scheu, S., J. Alferink, T. Pötzel, W. Barchet, U. Kalinke, and K. Pfeffer. 2002. Targeted disruption of LIG HT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin β in mesenteric lymph node genesis. J. Exp. Med. 195:1613-1624. https ://doi. org /10. 1084 /jem. 20020215
17. Shiraishi, H., M. Masuoka, S. Ohta, S. Suzuki, K. Arima, K. Taniguchi, S. Aoki, S. Toda, T. Yoshimoto, N. Inagaki, et al. 2012. Periostin contributes to the pathogenesis of atopic dermatitis by inducing TSLP production from keratinocytes. Allergol. Int. 61:563-572. https ://doi. org /10. 2332 / allergolint. 10-OA-0297
18. Sidhu, S.S., S. Yuan, A.L. Innes, S. Kerr, P.G. Woodruff, L. Hou, S.J. Muller, and J.V. Fahy. 2010. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc. Natl. Acad. Sci. USA. 107:14170-14175. https ://doi. org /10. 1073 /pnas. 1009426107
19. Steinberg, M.W., J.W. Shui, C.F. Ware, and M. Kronenberg. 2009. Regulating the mucosal immune system: the contrasting roles of LIG HT, HVEM, and their various partners. Semin. Immunopathol. 31:207-221. https ://doi. org /10. 1007 /s00281-009-0157-4
20. Sun, L.D., F.L. Xiao, Y. Li, W.M. Zhou, H.Y. Tang, X.F. Tang, H. Zhang, H. Schaarschmidt, X.B. Zuo, R. Foelster-Holst, et al. 2011. Genomewide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population. Nat. Genet. 43:690-694. https ://doi. org /10. 1038 /ng. 851
21. Takayama, G., K. Arima, T. Kanaji, S. Toda, H. Tanaka, S. Shoji, A.N. McKenzie, H. Nagai, T. Hotokebuchi, and K. Izuhara. 2006. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J. Allergy Clin. Immunol. 118:98-104. https ://doi. org /10. 1016 /j. jaci. 2006. 02. 046
22. Taniguchi, K., K. Arima, M. Masuoka, S. Ohta, H. Shiraishi, K. Ontsuka, S. Suzuki, M. Inamitsu, K.I. Yamamoto, O. Simmons, et al. 2014. Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1a/IL-6 loop. J. Invest. Dermatol. 134:1295-1304. https ://doi. org /10. 1038 /jid. 2013. 500
23. Usategui, A., G. Criado, E. Izquierdo, M.J. Del Rey, P.E. Carreira, P. Ortiz, W.J. Leonard, and J.L. Pablos. 2013. A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis. Ann. Rheum. Dis. 72:2018-2023. https ://doi. org /10. 1136 /annrheumdis-2012-202279
24. Yamamoto, T. 2009. Scleroderma-pathophysiology. Eur. J. Dermatol. 19:14-24
25. Yang, L., S. Serada, M. Fujimoto, M. Terao, Y. Kotobuki, S. Kitaba, S. Matsui, A. Kudo, T. Naka, H. Murota, and I. Katayama. 2012. Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma. PLoS One. 7:e41994. https ://doi. org /10. 1371 /journal. pone. 0041994
26. Yoo, J., M. Omori, D. Gyarmati, B. Zhou, T. Aye, A. Brewer, M.R. Comeau, D.J. Campbell, and S.F. Ziegler. 2005. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J. Exp. Med. 202:541-549. https ://doi. org /10. 1084 /jem. 20041503
27. Zhou, H.M., J. Wang, C. Elliott, W. Wen, D.W. Hamilton, and S.J. Conway. 2010. Spatiotemporal expression of periostin during skin development and incisional wound healing: lessons for human fibrotic scar formation. J. Cell Commun. Signal. 4:99-107. https ://doi. org /10. 1007 /s12079-010-0090-2
28. Ziegler, S.F., and D. Artis. 2010. Sensing the outside world: TSLP regulates barrier immunity. Nat. Immunol. 11:289-293. https ://doi. org /10. 1038 /ni. 1852